Governance Moderna, Inc.

MRNA

US60770K1079

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 01:57:16 07/02/2026 am IST			5-day change	1st Jan Change
40.57 ^USD	-0.73%		-8.34%	+36.98%

30/01	Leerink Partners Adjusts Moderna Price Target to $17 From $18, Maintains Underperform Rating	MT
30/01	Mib Outperforms Europe Ahead of S&P, Campari Leads Gains	AN

Executive Committee: Moderna, Inc.

Manager

Positions heldSince

Stéphane Bancel

54 year

Chief Executive Officer

01/03/2011

Jerh Collins

Chief Tech/Sci/R&D Officer

01/01/2023

James Mock

49 year

Director of Finance/CFO

06/09/2022

Shannon Klinger

55 year

General Counsel	01/06/2021
Corporate Secretary	01/06/2021

Jacqueline Miller

54 year

Chief Tech/Sci/R&D Officer

07/11/2024

Lavina Talukdar

Investor Relations Contact

01/04/2019

Tracey Franklin

46 year

Chief Tech/Sci/R&D Officer	07/11/2024
Human Resources Officer	31/10/2019

Stephen Hoge

50 year

President

01/11/2024

Composition of the Board of Directors: Moderna, Inc.

Director

CommitteesSince

Noubar Afeyan

62 year

Compensation Committee Chair	01/01/2005
Nominating Committee Chair	01/01/2005

Elizabeth Tallett

77 year

Audit Committee
Compensation Committee
HR Committee
Governance Committee	01/06/2011
Nominating Committee
Compensation Committee Chair	01/01/2011
Audit Committee Chair	01/01/2021

Elizabeth Nabel

74 year

Compensation Committee Chair
Compensation Committee
HR Committee
Audit Committee	01/04/2021
Governance Committee	01/01/2023
Nominating Committee	01/01/2023

Francois Nader

69 year

Compensation Committee Chair
HR Committee Chair
Governance Committee Chair	11/12/2019
Nominating Committee Chair	11/12/2019

Paul Sagan

66 year

Audit Committee	01/01/2021
Governance Committee	01/02/2021
Nominating Committee	19/12/2025
Compensation Committee	19/12/2025

Sandra Horning

77 year

Governance Committee	13/11/2020
Nominating Committee	13/11/2020

Shah Hussain

61 year

Audit Committee

02/10/2024

David Rubenstein

76 year

Audit Committee

05/08/2024

Stéphane Bancel

54 year

Director/Board Member

01/03/2011

Latest Appointments: Moderna, Inc.

30/01	Moderna, Inc. Announces Executive and Committee Changes, Effective March 2, 2026	CI
30/01	Moderna CMO Jacqueline Miller to step down	RE
29/01	Satellos Bioscience Inc. Appoints Antoinette Paone as Chief Development Officer and Head of Regulatory Affairs	CI
20/12	Okta, Inc. Announces Board Changes	CI
24/25/24	US CDC's report shows no evidence linking thimerosal-containing vaccines and autism	RE
12/25/12	Kennedy replaces fired US CDC panel members, includes anti-vaccine proponents	RE
12/25/12	Kennedy replaces fired US CDC panel members, includes anti-vaccine proponents	RE

More news

Former Officers and Directors: Moderna, Inc.

Insider

Positions held

SinceUntil

Kate Cronin

Corporate Officer/Principal

12/07/2021

01/04/2025

Melanie Ivarsson

Corporate Officer/Principal

30/01/2020

01/11/2024

Robert Langer

Director/Board Member	01/12/2010	05/08/2024
Founder	01/01/2010	05/08/2024
Independent Dir/Board Member	01/12/2010	05/08/2024

Stephen Berenson

Director/Board Member	01/10/2017	05/08/2024
Independent Dir/Board Member	01/10/2017	05/08/2024

Jonathan Hoggatt

Corporate Officer/Principal

01/10/2023

01/06/2024

Arpa Garay

Corporate Officer/Principal

31/05/2022

08/12/2023

Ronald Filippo

Corporate Officer/Principal

01/09/2021

01/11/2023

Juan Andres

Chief Tech/Sci/R&D Officer	01/08/2017	01/01/2023
Corporate Officer/Principal	01/01/2023	31/05/2023

Brad Miller

Chief Tech/Sci/R&D Officer

03/01/2023

Paul Burton

Chief Tech/Sci/R&D Officer

06/07/2021

01/01/2023

Stephanie Engels

Corporate Officer/Principal

01/07/2020

01/11/2022

Jorge Gomez

Director of Finance/CFO

09/05/2022

10/05/2022

David Meline

Director of Finance/CFO	08/06/2020	09/05/2022
Director of Finance/CFO	10/05/2022	06/09/2022

Corinne Le Goff

Corporate Officer/Principal

19/01/2021

01/01/2022

Marcello Damiani

Corporate Officer/Principal

01/09/2018

01/01/2022

Tal Zaks

Chief Tech/Sci/R&D Officer

01/03/2015

06/07/2021

Lori M. Henderson

General Counsel	01/04/2018	01/06/2021
Corporate Secretary	01/04/2018	01/06/2021

José M. Vega

Corporate Officer/Principal

11/01/2021

John Lepore

Corporate Officer/Principal

10/08/2020

Raymond C. Jordan

Corporate Officer/Principal

15/06/2020

Lorence Kim

Director of Finance/CFO	01/04/2014	08/06/2020
Investor Relations Contact	01/04/2014	08/06/2020

Patrick Norman Bergstedt

Corporate Officer/Principal

01/06/2020

Moncef Slaoui

Director/Board Member	01/07/2017	15/05/2020
Independent Dir/Board Member	01/07/2017	15/05/2020

Jennifer Ling Lee

Comptroller/Controller/Auditor

02/01/2020

Megan E. Pace

Corporate Officer/Principal

01/04/2018

01/01/2020

Peter Hutt

Director/Board Member	01/03/2012	09/12/2019
Independent Dir/Board Member	01/03/2012	09/12/2019

Jeffrey Cerio

Corporate Officer/Principal

01/06/2018

01/11/2019

Colleen Hussey

Public Communications Contact

01/08/2019

Robert Dolski

Corporate Officer/Principal

01/06/2016

01/05/2019

Anne Drapeau

Human Resources Officer

01/10/2016

01/05/2019

Stephen Harbin

Corporate Officer/Principal

01/08/2017

01/04/2019

Christoph Brackmann

Corporate Officer/Principal

01/01/2019

Theodore Ashburn

Corporate Officer/Principal

01/09/2017

01/07/2018

Richard J. Wanstall

Director of Finance/CFO

01/07/2014

01/07/2018

Giuseppe Ciaramella

Chief Tech/Sci/R&D Officer

01/01/2014

01/02/2018

Lee Cooper

Corporate Officer/Principal

01/06/2015

31/12/2017

Jason Glashow

Public Communications Contact

01/12/2017

Wendy Arnold

Human Resources Officer

01/01/2014

01/12/2017

Matthew Stanton

Corporate Officer/Principal

01/04/2014

01/09/2017

Barry Ticho

Corporate Officer/Principal

01/02/2016

01/09/2017

Saqib Islam

Corporate Officer/Principal

01/02/2016

01/08/2017

Henri A. Termeer

Director/Board Member

12/05/2017

Jim Kasinger

General Counsel	01/04/2014	01/05/2017
Corporate Secretary	01/04/2014	01/05/2017

Israel Ruiz

Director/Board Member	01/02/2017	-
Independent Dir/Board Member	01/02/2017	-

Francine Gregoire

Corporate Officer/Principal

01/11/2013

01/03/2016

Theo Melas-Kyriazi

Director/Board Member

01/01/2014

01/01/2016

Paula Soteropoulos

Corporate Officer/Principal

01/07/2013

01/12/2014

Louis St. Laurence O'Dea

Chief Tech/Sci/R&D Officer

01/01/2012

01/06/2014

John Mendlein

Director/Board Member	01/02/2019	-
Corporate Officer/Principal	31/01/2018	01/02/2019

Derrick J. Rossi

Founder

01/01/2010

Kenneth R. Chien

Founder

01/01/2010

John V. W. Reynders

Chief Tech/Sci/R&D Officer

Christine Swenson

General Counsel

Igor Smolenov

Chief Tech/Sci/R&D Officer

Douglas Cole

Director/Board Member	-	-
Founder	-	-

Leiden Dworak

Director/Board Member

Gregory Licholai

Corporate Officer/Principal

Axel Bouchon

Corporate Officer/Principal

Scott Sudduth

Corporate Officer/Principal

Paula Hammond

Consultant / Advisor

Joe Bolen

Chief Tech/Sci/R&D Officer	-	-
President	-	-

Kate Beresford O'Malley

Public Communications Contact

Age distribution of managers

Parity Men Women

Male	14
Female	3

Of which Executive Committee

Male	6
Female	2

Of which Directors

Male	8
Female	1

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (96.1%); - revenue from collaboration agreements (1.5%); - revenue from royalties and licensing (1.3%); - revenue from grants (1.1%). At the end of 2024, the group's portfolio comprises 37 products in clinical development, of which 10 in phase I, 18 in phase II and 9 in phase III, 3 products in preclinical development, and 4 products in commercial phase. Net sales are distributed geographically as follows: the United States (55.1%), Europe (18.5%) and other (26.4%).

Employees

5,800

Sector

Pharmaceuticals

Calendar

13/02 - Q4 2025 Earnings Release

More about the company